References
- Liang KP, Tleyjeh IM, Wilson WR, Roberts GD, Temesgen Z. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. J Clin Microbiol 2006; 44: 892–898
- Macdonell RA, Donnan GA, Kalnins RM, Richards MJ, Bladin PF. Otocerebral mucormycosis – a case report. Clin Exp Neurol 1987; 23: 225–232
- Numa, WA, Jr, Foster, PK, Wachholz, J, , et al. Cutaneous mucormycosis of the head and neck with parotid gland involvement: first report of a case. Ear Nose Throat J 2004; 83: 282, 284, 286 passim.
- Chandu A, MacIsaac RJ, MacGregor DP, et al. A case of mucormycosis limited to the parotid gland. Head Neck 2005; 27: 1108–1111
- Ellis JJ, Ajello L. An unusual source for Apophysomyces elegans and a method for stimulating sporulation of Saksenaea vasiformis. Mycologia 1982; 74: 144–145
- Padhye AA, Ajello L. Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis. J Clin Microbiol 1988; 26: 1861–1863
- Misra PC, Srivastava KJ, Lata K. Apophysomyces, a new genus of the Mucorales. Mycotaxon 1979; 8: 377–382
- Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25: 215–229
- Chakrabarti A, Das A, Mandal J, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 2006; 44: 335–342
- Even-Tov E, Niv A, Kraus M, Nash M. Candida parotitis with abscess formation. Acta Otolaryngol 2006; 126: 334–336
- De Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi. Centraalbureau voor Schimmelcultures, UtrechtThe Netherlands 2000
- Saksena SB. A new genus of the Mucorales. Mycologia 1953; 45: 426–436
- Chakrabarti A., Ghosh A, Prasad GS, et al. Apophysomyces elegans: an emerging zygomycete in India. J Clin Microbiol 2003; 41: 783–788
- Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am 2006; 20: 581–607
- Van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006; 42: e61–65